Under construction – not a live service
Sign in
Taking people in ChinaNo phase

Following People with Heart and Blood Vessel Diseases Over Time

Follows adults with heart failure or coronary artery disease to record their health outcomes.

Plain-language title generated from the registry record
Registry title: Clinical Outcomes of Cardiovascular Disease

Key facts

Where
Ürümqi, ChinaSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 80 years old?

Source: NCT06459934, who can take part

Where in China

  • The First Affiliated Hospital of Xinjiang Medicial UniversityÜrümqi, ChinaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Xinjiang Medical University
Trial code
NCT06459934
Record updated
18 June 2024
Original description
This study is a prospective, single center cohort study that primarily registers the clinical characteristics, outcomes, and influencing factors of patients with different types of cardiovascular diseases. Evaluate multiple examination indicators of patients at baseline, 1 year and longer, and follow up on the incidence of major cardiovascular and cerebrovascular adverse events, heart failure readmission, death, and other endpoint events.Read full original descriptionShow less

Clinical Outcomes of Cardiovascular Disease: a Prospective Cohort Study

This study is a prospective, single center cohort study that primarily registers the clinical characteristics, outcomes, and influencing factors of patients with different types of cardiovascular diseases. Evaluate multiple examination indicators of patients at baseline, 1 year and longer, and follow up on the incidence of major cardiovascular and cerebrovascular adverse events, heart failure readmission, death, and other endpoint events.

Inclusion: Coronary heart disease According to coronary angiography and coronary CTA, at least one coronary artery has a degree of stenosis greater than 50%; Hypertension Hypertension is defined as office systolic blood pressure is ≥ 140mmHg and/or the diastolic blood pressure is ≥ 90mmHg without the use of antihypertensive drugs; Heart failure There is a clear history of organic heart disease, clinical symptoms and signs of heart failure, and objective evidence of heart failure; Cardiomyopathy Including defined dilated cardiomyopathy, hypertrophic cardiomyopathy, restrictive cardiomyopathy, etc; Able to sign informed consent form.

Exclusion: Patients with various malignant tumors; Liver dysfunction (defined as ALT or total bilirubin greater than three times the upper normal limit); Renal insufficiency (defined as blood creatinine exceeding 1.5 times the upper normal limit); Age<18 years old, or>80 years old; Those who have participated in other clinical studies within the past three months; Individuals without legal capacity or with limited legal capacity; Any situation where the researcher deems it unsuitable to participate in the clinical study.

ClinicalTrials.gov NCT06459934